Buchumschlag

DRAM1‐defined autophagy‐JAK‐STAT‐Tregs axis drives immunosuppression and predicts immunotherapy response in pan‐cancer

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Jinchun Wu, Hailing Yang, Jingjing Cao, Min Yang, Wanqiao Cao, Yonglei Liu, Yunfeng Cheng, Fanli Hua
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	Clinical and Translational Discovery
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

SAA1 and metabolomic signatures predict hyperprogression with immunotherapy in pan cancers
von: Xiaoqing Wang, et al.
Veröffentlicht: (2024)

Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy
von: Jie Mei, et al.
Veröffentlicht: (2024)

Toward precision oncology: An integrative multi‐omics approach for prognosis prediction and inferred immunotherapy responsiveness in breast cancer
von: Houda Bendani, et al.
Veröffentlicht: (2026)

Regulatory mechanism of O‐linked N‐acetylglucosamine protein modification on autophagy in cancer
von: Yizhan Li, et al.
Veröffentlicht: (2026)

Tumour‐associated macrophage‐derived DOCK7‐enriched extracellular vesicles drive tumour metastasis in colorectal cancer via the RAC1/ABCA1 axis
von: Weiwei Chen, et al.
Veröffentlicht: (2024)

Comprehensive pan‐cancer analysis of mitochondrial outer membrane permeabilisation activity reveals positive immunomodulation and assists in identifying potential therapeutic targets for immunotherapy resistance
von: Qingshan Chen, et al.
Veröffentlicht: (2024)

Spatial transcriptomics deciphers the immunosuppressive microenvironment in colorectal cancer with tumour thrombus
von: Heming Ge, et al.
Veröffentlicht: (2024)

Role of tertiary lymphoid structures in the tumour microenvironment and immunotherapy response of renal cell carcinoma
von: Lin Yang, et al.
Veröffentlicht: (2025)

Proteogenomic characterisation of primary oral cancer unveils extracellular matrix remodelling and immunosuppressive microenvironment linked to lymph node metastasis
von: Yu Liu, et al.
Veröffentlicht: (2025)

A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response
von: Bing Feng, et al.
Veröffentlicht: (2024)

Sex differences in genomics, immune microenvironment and immunotherapy response in adult grade 4 gliomas
von: Feng Tang, et al.
Veröffentlicht: (2026)

Targeting one‐carbon metabolism for cancer immunotherapy
von: Xinxin Ren, et al.
Veröffentlicht: (2024)

Modulating commensal bacteria to intervene in cancer immunotherapy
von: Dingjiacheng Jia, et al.
Veröffentlicht: (2024)

Engineering a “muco‐trapping” ACE2 ‐immunoglobulin hybrid with picomolar affinity as an inhaled, pan‐variant immunotherapy for COVID ‐19
von: Karthik Tiruthani, et al.
Veröffentlicht: (2024)

iDICss robustly predicts melanoma immunotherapy response by synergizing genomic and transcriptomic knowledge via independent component analysis
von: Jiayue Qiu, et al.
Veröffentlicht: (2025)

Single‐cell dissection reveals immunosuppressive F13A1+ macrophage as a hallmark for multiple primary lung cancers
von: Chenglin Yang, et al.
Veröffentlicht: (2024)

Predictive circulating biomarkers of the response to anti‐PD‐1 immunotherapy in advanced HER2 negative breast cancer
von: Yuhan Wei, et al.
Veröffentlicht: (2025)

VAMP7‐mediated autophagy regulates cervical cancer progression associated with persistent HPV16 infection
von: Weijuan Xin, et al.
Veröffentlicht: (2026)

Harnessing the power of ionising radiation to enhance cancer immunotherapy
von: Kai Pang, et al.
Veröffentlicht: (2025)

Longitudinal circulating tumour DNA dynamics predict failure patterns and efficacy of consolidation immunotherapy after chemoradiotherapy in locally advanced non‐small‐cell lung cancer
von: Yu Wang, et al.
Veröffentlicht: (2024)

A case of immunotherapy‐responsive autoimmune hemichorea
von: Rachel E. Rodin, et al.
Veröffentlicht: (2024)

NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence
von: Marina Mendiburu‐Eliçabe, et al.
Veröffentlicht: (2024)

Targeting autophagy: A promising approach for the treatment of breast cancer brain metastases
von: Steffan T. Nawrocki, et al.
Veröffentlicht: (2024)

ALKBH3 suppresses ischemia/reperfusion‐induced PANoptosis by regulating the ZBED6/STAT1/AIM2 axis through m 1 A demethylation
von: Hongtao Diao, et al.
Veröffentlicht: (2026)

GPR183 ‐mediated activation of PI3K is a potential biomarker for immunotherapy in lung cancer
von: Ling Ye, et al.
Veröffentlicht: (2026)

CD31 regulates metabolic switch in Treg migration attenuates rheumatoid arthritis
von: Meijun Liu, et al.
Veröffentlicht: (2025)

NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy
von: Alaa Alsalloum, et al.
Veröffentlicht: (2024)

Macrophage OTUD1‐CARD9 axis drives isoproterenol‐induced inflammatory heart remodelling
von: Jinfu Qian, et al.
Veröffentlicht: (2024)

Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinib
von: Steffan T. Nawrocki, et al.
Veröffentlicht: (2024)

Lymphocyte activation gene 3 served as a potential prognostic and immunological biomarker across various cancer types: a clinical and pan‐cancer analysis
von: Yifan Liu, et al.
Veröffentlicht: (2024)

CD103+CD8+ tissue‐resident memory T lymphocytes of melanoma boost anti‐tumour immunity and predict immunotherapy outcomes
von: Tianyi Zhang, et al.
Veröffentlicht: (2025)

Baseline multi‐omics signatures could predict therapeutic response to neoadjuvant anti‐PD‐1 immunochemotherapy in non‐small‐cell lung cancer
von: Ailing Cao, et al.
Veröffentlicht: (2026)

Targeting PMN‐MDSCs via CD300ld receptor for cancer immunotherapy
von: Yuwei Li, et al.
Veröffentlicht: (2024)

Multi‐omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited‐stage small cell lung cancer to definitive chemoradiotherapy
von: Li Li, et al.
Veröffentlicht: (2024)

Immune responsiveness in stable kidney transplantation patients: Complete inhibition of T‐cell proliferation but residual T‐cell activity during maintenance immunosuppressive treatment
von: Aliede E. in ’t Veld, et al.
Veröffentlicht: (2024)

scICB: A pan‐cancer database of human temporal immune checkpoint blockade therapy at single‐cell transcriptomic resolution
von: Fansen Ji, et al.
Veröffentlicht: (2025)

The co‐location of CD14+APOE+ cells and MMP7+ tumour cells contributed to worse immunotherapy response in non‐small cell lung cancer
von: Guangyu Fan, et al.
Veröffentlicht: (2024)

Established a therapeutic response prediction model in metastatic gastric cancer by liquid biopsy
von: Sheng Liu, et al.
Veröffentlicht: (2024)

An exosome‐based liquid biopsy signature for therapeutic response prediction in metastatic gastric cancer
von: Keisuke Okuno, et al.
Veröffentlicht: (2024)

Unravelling T cell exhaustion through co‐inhibitory receptors and its transformative role in cancer immunotherapy
von: Simin Xiang, et al.
Veröffentlicht: (2025)